Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Inc

214.79
-1.6200-0.75%
Pre-market: 214.800.0100+0.00%06:16 EDT
Volume:1.05M
Turnover:226.78M
Market Cap:25.73B
PE:50.56
High:217.20
Open:217.19
Low:213.65
Close:216.41
Loading ...

Director Trac Pham Reports Disposal of Common Shares in PTC Inc

Reuters
·
13 May

PTC India Financial Services Logs Sharp Rise in Fiscal Q4 Consolidated Net Profit

MT Newswires Live
·
12 May

PTC Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
10 May

BofA Upgrades PTC Therapeutics to Buy From Neutral, Adjusts Price Target to $68 From $55

MT Newswires Live
·
09 May

PTC Therapeutics Raised to Buy From Neutral by B of A Securities

Dow Jones
·
09 May

PTC Therapeutics upgraded to Buy from Neutral at BofA

TIPRANKS
·
09 May

PTC Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
08 May

PTC Therapeutics Is Maintained at Overweight by JP Morgan

Dow Jones
·
07 May

Citigroup Upgrades PTC Therapeutics to Neutral From Sell, Adjusts Price Target to $40 From $50

MT Newswires Live
·
07 May

PTC Therapeutics Swings to Q1 Earnings, Revenue Increases

MT Newswires Live
·
07 May

PTC Therapeutics (PTCT) Q1 2025 Earnings Call

Motley Fool Transcribing
·
07 May

PTC Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
07 May

PTC Therapeutics Q1 EPS $10.04, Sales $1.18B

Benzinga
·
07 May

Scotiabank Keeps Their Hold Rating on PTC Therapeutics (PTCT)

TIPRANKS
·
06 May

Hold Rating for PTC Therapeutics Amid Mixed Clinical Results and Uncertain FDA Approval Prospects

TIPRANKS
·
06 May

Why Did PTC Therapeutics Stock Fall On Monday Despite Mid-Stage Study For Huntington's Hits Primary Goal?

Benzinga
·
06 May

Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), PTC Therapeutics (PTCT) and Larimar Therapeutics (LRMR)

TIPRANKS
·
06 May

RBC Capital Adjusts PTC Therapeutics Price Target to $57 From $65, Maintains Outperform Rating

MT Newswires Live
·
05 May

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Agilent (A), Andlauer Healthcare Group (OtherANDHF) and PTC Therapeutics (PTCT)

TIPRANKS
·
05 May

PTC Therapeutics Says Phase 2 Votoplam Trial in Huntington's Disease Meets Primary Endpoint

MT Newswires Live
·
05 May